3. ANÁLISIS DE MERCADO
3.3. Situación Actual y Proyección de Exportaciones
76 8/8/2019 Harper DM. Cervical Cancer Screening among US Native Americans. 48th Annual Meeting & Health Conference Association of American Indian Physicians. Chicago, IL.
75 2/20/2011 Harper DM. HPV: What New Places Does it Live, What New Diseases Does it Cause?
Panelist on the Oral Sex is Sex and Can Lead to Cancer Plenary sponsored by the Section of Dentistry and Oral Health at the American Association for the Advancement of Science (AAAS) 177th Annual Meeting, Washington DC.
74 10/3/2009 Harper DM. Cervical Cancer Prevention- Gardasil Vaccination: Informed Consent? The 4th
International Public Conference on Vaccination. Reston VA.
73 5/4/2008 Harper DM. Impact of HPV vaccines beyond the cervix. Course 060. Annual Clinical
Meeting. ACOG, New Orleans, LA.
72 5/4/2008 Harper DM. Current Status of HPV vaccines and Cervical Cancer. Course 060. Annual
71 5/4/2008 Harper DM. Pathophysiology of HPV Disease. Course 060. Annual Clinical Meeting. ACOG,
New Orleans, LA.
70 8/10/2007 Harper DM. Human Papillomavirus Symposium: HPV Vaccines. Infectious Diseases Society
for Obstetrics and Gynecology, 34th Annual Scientific Meeting, Boston, MA
69 8/1/2007 Harper DM. HPV Vaccines. RWJ Foundation Translating Research into Policy Conference,
Princeton, NJ
68 5/5/2007 Harper DM. Current Status of HPV vaccines. Course 060. Annual Clinical Meeting. ACOG,
San Diego, CA.
67 5/5/2007 Harper DM. Pathophysiology of HPV Disease. Course 060. Annual Clinical Meeting. ACOG,
San Diego, CA.
66 3/14/2007 Harper DM. The changing face of cervical cancer prevention. Presented at The Immune
System and Reproductive Processes Symposium. Society of Gynecologic Investigation. Reno, NV.
65 3/1/2007 Harper DM. What does HPV vaccination buy? Planned Parenthood. Steamboat Springs,
CO.
64 2/21/2007 Harper DM. HPV Immunology from Vaccination. Chicago Society of Gynecologists.
Chicago, IL.
63 11/4/2006 Harper DM. Pap Screening in the Era of HPV Vaccines. Vermont Academy of Family
Physicians. Montpelier, VT.
62 10/17/2006 Harper DM. HPV Vaccine Successes and Limitations. 10th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies: Basic, Epidemiologic and Clinical Research. US NIH; NCI; Office of AIDS Malignancy Program and Office of International Affairs, Washington DC.
61 10/13/2006 Harper DM. HPV Vaccine Update: Benefits and Limitations. National Coalition of STD
Directors, San Diego, CA.
60 10/3/2006 Harper DM. HPV Vaccination, Screening, and Treatment. National Cervical Cancer
Coalition. Washington DC.
59 6/3/2006 Harper DM. Cancer Screening to Vaccination: The Bridge. American Society of Clinical
Oncology, Atlanta, GA.
58 5/16/2006 Harper DM. Norris Cotton Cancer Center Gynecologic Oncology Update about Cervical
Cancer. Lebanon, NH.
57 5/10/2006 Harper DM. HPV Infection and Cancers: How to prevent them. Connecticut Infectious
Diseases Society. Hartford, CT.
56 5/8/2006 Harper DM. An overview of the state of the art of HPV vaccines. 2006 National STD
Prevention Conference, Jacksonville, FL.
55 5/6/2006 Harper DM. HPV Education. Presented to ACOG Annual Meeting, Washington DC. 54 4/1/2006 Harper DM. HPV Vaccination: Future Effects. Planned Parenthood National Meeting.
Miami, FL.
53 3/21/2006 Harper DM. HPV Vaccines. Society for Gynecologic Oncology, Boston MA.
52 3/16/2006 Harper DM. American Society for Colposcopy and Cervical Pathology Biennial Meeting,
Normal Cervix: Cytology, Colposcopy and Histology, Las Vegas, NV.
51 3/6/2006 Harper DM. Keynote Speaker, HPV Vaccines of the Future, at 40th National Immunization Program, Centers for Disease Control and Prevention, Atlanta GA.
50 1/7/2006 Harper DM. Understanding Implementation Issues for HPV Vaccines. Women in
49 12/15/2005 Harper DM. HPV Vaccine Efficacy, Tolerability and Role in Cervical Cancer Prevention.
Interscience Conference on Antimicrobial Agents and Chemotherapy. 45th Annual Conference, Washington DC.
448 12/6/2005 Harper DM. The Status of Cervical Cancer Vaccine Research. Briefing for Reps. Shelley
Monroe Capito, Tammy Baldwin, Ginny Brown-Waite and Hilda L. Solis for the Women’s Health Task Force and the Congressional Caucus for Women’s Issues with Women’s Policy, Inc. Rayburn House Office Building, Washington DC.
47 10/29/2005 Harper DM. Facilitation of Pediatrics Advisory Board for HPV Vaccination. Chicago, IL. 46 10/18/2005 Harper DM. Symposium on Prevention of Cervical Cancer and other HPV Related Diseases.
61st Annual Meeting of the American Society of Reproductive Medicine. Montreal, QC.
45 10/10/2005 Harper DM. HPV Detection - Clinical and Health Care Policy Considerations. American
Academy of Pediatrics. Washington DC.
44 9/26/2005 Harper DM. The pathophysiology and psychology of HPV. CDC Advisory Meeting, Atlanta,
GA.
43 9/23/2005 Harper DM. HPV Vaccine Efficacy, Immunogenicity, and Tolerability. 45th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, American Society of Microbiology. New Orleans, LA.
42 9/22/2005 Harper DM. Immunization Cross Reactivity Among Alpha Genera. GSK. King of Prussia PA. 41 9/15/2005 Harper DM. Psychomotor Skills Task Force to design the clinical teaching test for the pelvic
exam. National Board of Medical Examiners. Philadelphia PA.
40 7/21/2005 Harper DM. Facilitator for the Elimination of Cervical Cancer Campaign Strategic Session.
Women in Government. Bay Harbor, MI.
39 6/29/2005 Harper DM. HPV Vaccines in Primary Care. Primary Care Advisory Committee, American
Cancer Society, Atlanta, GA.
38 5/20/2005 Harper DM. HPV Vaccine Update. NCI Sponsored Workshop on Cervical Cancer Prevention,
MD Anderson Cancer Center, Houston TX.
37 5/19/2005 Harper DM. Patient Decision Making in Cervical Cancer Screening. NCI Sponsored
Workshop on Cervical Cancer Prevention, MD Anderson Cancer Center, Houston TX.
36 5/17/2005 Harper DM. Spectroscopic Imaging of Cervical Neoplasia and Cancer. FDA Panel Hearing.
Washington DC.
35 5/15/2005 Harper DM. HPV Vaccination. Pediatric Academic Societies Annual Meeting, Washington
DC.
34 4/8/2005 Harper DM. Adoption of Vaccines in Development: HPV, Shingles and Rotavirus, Mt. Sinai
Department of Infectious Diseases, New York, NY.
33 3/18/2005 Harper DM. The role of HPV testing at HPV vaccination implementation. Society for
Gynecologic Oncologists Annual Meeting, Miami Beach, FL.
32 3/17/2005 Harper DM. Testifying to the Health, Education, Labor and Pensions (HELP) Committee of
the US Senate about the impact of HPV disease. Washington DC.
31 3/8/2005 Harper DM. Sixteenth Annual Cancer Progress Conference. HPV Vaccines: True Prevention
of Cervical Cancer. New York City, NY.
30 3/1/2005 Harper DM. Inaugural Health Care Conference for Cancer Prevention. Vaccination to
Prevent Cancer. New York City, NY.
29 1/12/2005 Harper DM. HPV Vaccines: Prevention of Cervical Ca. University of Ca- Irvine Chao Family
Comprehensive Cancer Center Grand Rounds, Orange County, CA.
28 12/4/2004 Harper DM. HPV Vaccine Updates. University of Kansas Academy of Family Physicians
27 12/3/2004 Harper DM. Controversies in HPV and Cervical Dysplasia Management. University of Kansas
Academy of Family Physicians Winter Symposium, Wichita KS.
26 12/2/2004 Harper DM. The Bethesda 2001 Nomenclature and Clinical Management Guidelines.
University of Kansas Academy of Family Physicians Winter Symposium, Wichita KS.
25 7/6/2004 Harper DM. Understanding HPV Vaccines. Michigan State University.
24 6/21/2004 Harper DM. Human Papillomavirus for the Practicing Physician. American Cancer Society Film for On-line, CD, and Public Television Distribution, New York City NY.
23 3/15/2004 Harper DM. Featured Morning Speaker: How does your clinic perspective matter in
economic analyses of cervical cancer screening? Wednesday, Mar 17, 2004 from 7:00 - 8:00 a.m. American Society for Colposcopy and Cervical Pathology Biennial Meeting, Orlando FL.
22 6/9/2003 Harper DM. The Bethesda 2001 Nomenclature, and Clinical Management Guidelines for
Abnormal Cervical Cytology and Histology. Rehoboth Beach Delaware. Pennsylvania Academy of Family Physicians.
21 3/3/2000 Harper DM. HPV is the most common STD. How should primary care doctors address this?
Presented to the Healthy Women 2000 conference, Baltimore, MD.
20 5/25/1999 Harper DM. Dialogue about the Abnormal Pap.Presented to the 1999 American Academy
of Physicians’ Assistants Assembly. Atlanta, GA.
19 9/13/1999 Harper DM. Frontiers in Cervical Cancer Screening. Presented to the 51st American Academy of Family Physicians Scientific Assembly. Orlando, FL.
18 9/13/1999 Harper DM. Does HPV Triage work for women with LSIL Pap Smears? Presented to the 51st American Academy of Family Physicians Scientific Assembly. Orlando, FL.
17 9/16/1998 Harper DM. Threshold Analysis in Medical Decision Making. Presented to the Stanford
Faculty Development Center, Palo Alto, CA.
16 9/18/1998 Harper DM. Case Studies with Clinical Experts. Presented to the 1998 50th American Academy of Family Physicians Scientific Assembly. San Francisco, CA.
15 9/19/1998 Harper DM. Management Strategies for the Abnormal Pap.Presented to the 1998 50th American Academy of Family Physicians Scientific Assembly. San Francisco, CA.
14 5/3-
5/7/1997
Harper DM. The Challenges and Obstacles of Women in Academic Family Medicine. Panel Discussion with Paul Nutting, MD, Larry Green, MD, Jonathan Rodnick, MD, and Bill Hueston, MD. Society for Teachers of Family Medicine Annual Conference.
13 9/20/1997 Harper DM. The Contraceptive Dilemma—What are you giving your patients? 49th Annual Scientific Convocation American Academy of Family Physicians, Chicago, IL.
12 9/20/1997 Harper DM. The Abnormal Pap Smear: What Is Indicated? 49th Annual Scientific Convocation American Academy of Family Physicians, Chicago, IL.
11 5/26/1996 Harper DM. Implications of the Abnormal Papanicolaou Smear. 24th Annual Conference of the American Academy of Physician Assistants. New York City, NY.
10 10/3-
10/6/1996
Harper DM. Management Strategies for a Positive Papanicolaou Smear. 48th Annual Scientific Convocation American Academy of Family Physicians, New Orleans, Louisiana.
9 9/22/1995 Harper DM. The Implications of the Abnormal Pap. Dialogue Session at American Academy
of Family Physicians 47th Annual Scientific Convocation, Anaheim, California.
8 9/22/1995 Harper DM. Papanicolaou Smear Implications. Ask the Lecturer. American Academy of
Family Physicians 47th Annual Scientific Convocation, Anaheim, California.
7 9/22/1995 Harper DM. The Abnormal Pap. Mainstage Lecture at American Academy of Family
Physicians 47th Annual Scientific Convocation, Anaheim, California.
6 10/15/1995 Harper DM. Teaching Medical Decision Making. Part II. 17th Annual Meeting of the
5 10/14/1995 Harper DM. Teaching Medical Decision Making. Part I. 17th Annual Meeting of the Society
for Medical Decision Making, Tempe, Arizona.
4 10/30/1995 Harper DM. Breast and Cervical Cancer Screening. American Medical Woman’s Association
National Convention, Seattle, Washington.
3 5/12/1993 Harper DM. Cervical Lesions. Presented to the National Rural Health Association. Kansas
City, MO.
2 12/3-
12/6/1992
Harper DM. The Design of a Cohort Study Comparing Cryotherapy to LEEP as Curative Therapies for Cervical Intraepithelial Neoplasia. Presented to the Mead Johnson Family Medicine Research Forum. Ft. Lauderdale, FL.
1 1/30/1985 Harper DM. Theories of Pregnancy Maintenance and Wastage: an Overview. Presented to
the Department of Gynecology and Obstetrics, University of Kansas School of Medicine, Kansas City, KS.